Announcements
5 November 2024
MDPI INSIGHTS: The CEO's Letter #17 - OA Week, Basel Open Day, Beijing Graphene Forum
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
Open Access Week: Forging the Future of Open Access through Global Reach and Collaboration
From 21 to 27 October, we celebrated International Open Access Week (OAW), highlighting the importance of making research accessible to everyone. This campaign reinforced our commitment to advancing open access (OA) and showcased how we are helping research communities worldwide adopt OA as their standard.
“OA publishing is now a cornerstone of global research”
Throughout the week, we featured MDPI’s efforts to support quality open research through blog posts on topics such as how Research Integrity Promotes OA Practices, our Preprints.org platform, and supporting societies with different OA models. These initiatives capture our commitment to making research more inclusive and accessible to all.
OA publishing is now a cornerstone of global research, with more researchers choosing OA over traditional paywalled models, and embracing new, community-driven models.
Benefits of Open Access and Open Research
- Accelerated Discoveries: OA speeds up scientific progress by allowing immediate access to findings, enabling researchers to build on each other’s work faster.
- Community-Led Innovation: Open research empowers communities to manage their own platforms, creating collaboration and shared knowledge.
- Increased Visibility: OA broadens the reach of your research, leading to greater recognition, collaboration, and impact.
- Cross-Disciplinary Connections: By removing financial and geographical barriers, OA unites diverse fields, sparking innovation across disciplines.
MDPI Singapore Celebrates Open Access Week
MDPI Singapore also hosted its first-ever OAW event at the Marina Bay Sands Convention Centre, bringing together academics, researchers, and students to discuss the future of open scholarship. Conversations focused on the potential of new publishing models, alternative funding strategies, and the importance of communicating research to wider audiences.
As OA evolves, MDPI remains a committed partner in advancing open science and creating a transparent, inclusive research environment. For a full recap of the week’s highlights and resources, visit our campaign page.
Impactful Research
MDPI Connection to Nobel-Winning Protein Research
David Baker, an American biochemist, and Demis Hassabis and John M. Jumper, two scientists from Google DeepMind, have been awarded the 2024 Nobel Prize in Chemistry for their groundbreaking advancements in better understanding the structure of proteins, the molecular engines of life’s processes.
One half of the prize was awarded to Professor David Baker from the University of Washington for his development of revolutionary protein design software enabling the creation of novel proteins for vaccines, nanomaterials, and sensors. Prof. Baker co-authored a 2016 paper in MDPI’s Toxins journal on protein-based therapeutics.
Meanwhile, DeepMind’s Demis Hassabis and John M. Jumper received recognition for AlphaFold, the AI model that predicts protein structures from amino acid sequences, fulfilling a long-held scientific dream.
“We congratulate this year’s Nobel laureates for their groundbreaking contributions to the study of life”
Nobel Prize Laureates Entrust MDPI with Their Research
As at October 2024, 45 Nobel laureates had contributed to more than 115 articles across
35 MDPI journals. The privilege of hosting the research of such contributors, who significantly influence the open access movement, resonates deeply with our editorial teams.
We are proud to list the names of Pierre Agostini, Hiroshi Amano, Werner Arber, Aaron Ciechanover, Robert H. Grubbs, Oliver Hart, Gerard ‘t Hooft, Michael Houghton, Harald zur Hausen, Katalin Karikó, Jean-Marie Lehn, Gérard Mourou, Ferid Murad, Shuji Nakamura, William Nordhaus, Kostya S. Novoselov, Giorgio Parisi, Charles M. Rice, Alvin E. Roth, Donna Strickland, K. Barry Sharpless, George F. Smoot, Anne L’Huillier, Drew Weissman, Kurt Wüthrich, Ada Yonath, Tomas Lindahl, Thomas C. Südhof, Stanley B. Prusiner, Roger Kornberg, Robert F. Engle, Richard J. Roberts, Ōmura Satoshi, Kenneth J. Arrow, John B. Goodenough, Jennifer Doudna, Hamilton Othanel Smith, Eric R. Kandel, Carlo Rubbia, Bernard Feringa, Barry J. Marshall, Anthony J. Leggett, Andrew Victor Schally, and David Baker.
Notable MRNA Published in Cells
On 7 October 2024, the 2024 Nobel Prize in Physiology or Medicine was jointly awarded to Victor Ambros and Gary Ruvkun for the discovery of microRNA and its role in post-transcriptional gene regulation.
MicroRNAs are proving to be fundamentally important for how organisms develop and function. Some interesting papers about microRNA research are published in the MDPI journal Cells. I invite you browse through the notable papers related to microRNA research in Cells.
Inside MDPI
Basel Open Day
On 21 October, we held the Basel Open Day at our headquarters, welcoming a group of journal Editors-in-Chief (EiC) and Editorial Board Members (EBMs) for a full-day workshop. The event featured presentations and discussions on MDPI’s latest editorial updates, data integrity policies, society collaborations, and local market insights.
The following MDPI journals were represented during the visit: Physics, Journal of Personalized Medicine (JPM), Sci, Remote Sensing, Animals, Cells, Buildings, Histories, Sensors, and International Journal of Environmental Research and Public Health (IJERPH).
This was a great opportunity to showcase our new office space while gathering feedback from leading journal stakeholders. To get everyone on the same page, we took 60 minutes for round-table introductions, which helped set a collaborative tone and ground us in MDPI’s mission of disseminating open science.
“This was a great opportunity to gather feedback from leading journal stakeholders”
The general feedback from the day highlighted positive developments around our editorial and ethics policies, as well as areas for improvement, including flexibility regarding reviewer deadlines. There was a genuine appreciation and push for our ongoing efforts to share more about MDPI, including company updates and promoting high-quality research through our blog, announcements, and social media channels, which we have been growing and expanding.
Our Basel Open Day was a positive experience, bringing together key journal stakeholders and gathering insights to guide MDPI’s continued engagement with the academic community. We look forward to hosting future events of this kind and welcoming more scholars to our headquarters in Basel, Switzerland.
Coming Together for Science
ncRNA 2024 Conference in Basel
I am pleased to share that we held Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines (ICM 2024) in Basel, Switzerland this past 7–9 October.
The three-day event attracted just over 100 attendees, including two Chairs, 10 invited speakers and two keynotes from Prof. Mauro Giacca and Prof. Ling-Ling Chen. Of the presentations on site, there were 35 posters and 44 oral presentations.
The overall feedback was positive, with people enjoying the intimate event and the unique activities offered, including a guided tour around Basel’s Old Town (a must-see for anyone visiting the city) and a memorable conference dinner.
It was cool to see the winners of the 2024 Nobel Prize in Physiology or Medicine announced during the conference days. This was exciting for attendees, as the winners discovered a new class of RNA molecules (miRNAs). As one invited speaker put it, “It's exciting to be among fellows when something that important for the field is announced.”
“It's exciting to be among fellows when something that important for the field is announced”
Every attendee receives a conference survey, and I’m always pleased to see a high percentage of ‘Very Satisfied’ responses when asked about ‘treatment from conference personnel’. Kudos to our conference team for meeting our attendees’ needs. These events are a great opportunity for us to reach new audiences, as 92% of the respondents had never been to an MDPI conference, so I am thrilled to see us connecting with a new demographic of your researchers in the RNA field.
A special thank-you to our partnering societies The Epigenetics Society, The French Society of Genetics, LS2 / USGEB (Union of Swiss Societies for Experimental Biology), and The RNA Biology Group, as well as to our sponsors New England Biolabs and Arraystar for their support of the ncRNA 2024 conference. I am also pleased to report that we presented two awards, including the Best Presentation Award and two Best Poster Award, recognizing the contributions of our participants.
Upcoming In-Person Event
27–29 November 2024
Pharmaceuticals 2024 – Recent Advances in Pharmaceutical Sciences Towards a Healthy Life
Location: Barcelona, Spain
The discovery of new molecules, their properties, and actions to enhance human health and quality of life.
Find more upcoming MDPI events here.
Closing Thoughts
Beijing Graphene Forum 2024
I am pleased to share that we had a successful time at the Beijing Graphene Forum 2024, which drew around 1,000 attendees, including Konstantin Novoselov (2015 Nobel Prize in Physics) and other high-profile scholars in materials science and chemistry. It was a great opportunity to present MDPI on the big stage, with university presidents from institutions such as Peking University also in attendance.
I had the honour of awarding Prof. Zhongfan Liu, Chairman of the Chemical Science Committee, with a medal and presenting certificates to the members of the Chemical Science Committee; this is an important initiative to help expand MDPI’s journals and influence in China. These are highly respected scholars, and we enjoyed connecting with them over lunch as well.
“This is an important initiative to help expand MDPI’s journals and influence in China”
I also had the chance to speak about MDPI and open access, giving a five-minute speech during the opening ceremony and a 20-minute presentation at the close. MDPI hosted a sub-forum where both academic scholars and MDPI members shared insights, and we engaged with attendees at our MDPI booth.
This was a great opportunity to spotlight MDPI as the main publishing partner for the event, and I was proud to represent us on stage. We also met with scholars to discuss topics such as their publishing needs and institutional policies, open access, impact journals, and IOAP.
Chief Executive Officer
MDPI AG
4 November 2024
Journal of Clinical Medicine | Notable Papers in Q3 of 2024
1 November 2024
Meet Us at the 63rd Annual Meeting of Japanese Retina and Vitreous Society, 6–8 December 2024, Osaka, Japan
28 October 2024
Journal of Clinical Medicine | Highly Cited Papers in 2023 and Hot Topic Special Issues on Clinical Pediatrics
We are delighted to share some highly cited papers on clinical pediatrics that were published in the Journal of Clinical Medicine (JCM, ISSN: 2077-0383) in 2023. In addition, some Special Issues in the Section “Clinical Pediatrics” are currently open for submission. The following is a list of articles and Special Issues that we believe will interest you.
1. “PCOS in Adolescents—Ongoing Riddles in Diagnosis and Treatment”
by Blazej Meczekalski, Olga Niwczyk, Anna Kostrzak, Marzena Maciejewska-Jeske, Gregory Bala and Anna Szeliga
J. Clin. Med. 2023, 12(3), 1221; https://doi.org/10.3390/jcm12031221
Available online: https://www.mdpi.com/2077-0383/12/3/1221
2. “Remimazolam as an Adjunct to General Anesthesia in Children: Adverse Events and Outcomes in a Large Cohort of 418 Cases”
by Yoshitaka Kimoto, Tatsuya Hirano, Norifumi Kuratani, David Cavanaugh and Keira P. Mason
J. Clin. Med. 2023, 12(12), 3930; https://doi.org/10.3390/jcm12123930
Available online: https://www.mdpi.com/2077-0383/12/12/3930
3. “Remimazolam for Pediatric Procedural Sedation: Results of an Institutional Pilot Program”
by Tatsuya Hirano, Yoshitaka Kimoto, Norifumi Kuratani, David Cavanaugh and Keira P. Mason
J. Clin. Med. 2023, 12(18), 5937; https://doi.org/10.3390/jcm12185937
Available online: https://www.mdpi.com/2077-0383/12/18/5937
4. “Necrotizing Pneumonia in Children: Early Recognition and Management”
by Yuanyuan Chen, Lanxin Li, Chenlu Wang, Yuanyuan Zhang and Yunlian Zhou
J. Clin. Med. 2023, 12(6), 2256; https://doi.org/10.3390/jcm12062256
Available online: https://www.mdpi.com/2077-0383/12/6/2256
5. “Diagnostic Utility of Serum Leucine-Rich α-2-Glycoprotein 1 for Acute Appendicitis in Children”
by Goran Tintor, Miro Jukić, Daniela Šupe-Domić, Ana Jerončić and Zenon Pogorelić
J. Clin. Med. 2023, 12(7), 2455; https://doi.org/10.3390/jcm12072455
Available online: https://www.mdpi.com/2077-0383/12/7/2455
6. “Cough Hypersensitivity Syndrome: Why Its Use Is Inappropriate in Children”
by Anne B. Chang, Richard S. Irwin, Hannah E. O’Farrell, Peter V. Dicpinigaitis, Suhani Goel, Ahmad Kantar and Julie M. Marchant
J. Clin. Med. 2023, 12(15), 4879; https://doi.org/10.3390/jcm12154879
Available online: https://www.mdpi.com/2077-0383/12/15/4879
7. “The Advanced Diabetes Technologies for Reduction of the Frequency of Hypoglycemia and Minimizing the Occurrence of Severe Hypoglycemia in Children and Adolescents with Type 1 Diabetes”
by Tatsuhiko Urakami
J. Clin. Med. 2023, 12(3), 781; https://doi.org/10.3390/jcm12030781
Available online: https://www.mdpi.com/2077-0383/12/3/781
8. “Mental Health and Health-Related Quality of Life in Austrian Adolescents with Chronic Physical Health Conditions: Results from the MHAT Study”
by Gudrun Wagner, Andreas Karwautz, Julia Philipp, Stefanie Truttmann, Wolfgang Dür, Karin Waldherr, Gabriele Berger and Michael Zeiler
J. Clin. Med. 2023, 12(5), 1927; https://doi.org/10.3390/jcm12051927
Available online: https://www.mdpi.com/2077-0383/12/5/1927
9. “Preclinical Application of Augmented Reality in Pediatric Craniofacial Surgery: An Accuracy Study”
by Federica Ruggiero, Laura Cercenelli, Nicolas Emiliani, Giovanni Badiali, Mirko Bevini, Mino Zucchelli, Emanuela Marcelli and Achille Tarsitano
J. Clin. Med. 2023, 12(7), 2693; https://doi.org/10.3390/jcm12072693
Available online: https://www.mdpi.com/2077-0383/12/7/2693
10. “Predictive Power of Oxygen Desaturation Index (ODI) and Apnea-Hypopnea Index (AHI) in Detecting Long-Term Neurocognitive and Psychosocial Outcomes of Sleep-Disordered Breathing in Children: A Questionnaire-Based Study”
by Marco Zaffanello, Giuliana Ferrante, Leonardo Zoccante, Marco Luigi Ciceri, Luana Nosetti, Laura Tenero, Michele Piazza and Giorgio Piacentini
J. Clin. Med. 2023, 12(9), 3060; https://doi.org/10.3390/jcm12093060
Available online: https://https://www.mdpi.com/2077-0383/12/9/3060
11. “CAR T-Cell Therapy in Children with Solid Tumors”
by Marika Kulczycka, Kamila Derlatka, Justyna Tasior, Monika Lejman and Joanna Zawitkowska
J. Clin. Med. 2023, 12(6), 2326; https://doi.org/10.3390/jcm12062326
Available online: https://www.mdpi.com/2077-0383/12/6/2326
12. “Protein Biomarkers in Chronic Kidney Disease in Children—What Do We Know So Far?”
by Agnieszka Rybi Szumińska, Anna Wasilewska and Monika Kamianowska
J. Clin. Med. 2023, 12(12), 3934; https://doi.org/10.3390/jcm12123934
Available online: https://www.mdpi.com/2077-0383/12/12/3934
13. “Elevated Neutrophil-to-Lymphocyte Ratio Is Associated with Severe Asthma Exacerbation in Children”
by Noga Arwas, Sharon Uzan Shvartzman, Aviv Goldbart, Romi Bari, Itai Hazan, Amir Horev and Inbal Golan Tripto
J. Clin. Med. 2023, 12(9), 3312; https://doi.org/10.3390/jcm12093312
Available online: https://www.mdpi.com/2077-0383/12/9/3312
14. “Finite Element Analysis of the Mechanical Performance of Non-Restorable Crownless Primary Molars Restored with Intracoronal Core-Supported Crowns: A Proposed Treatment Alternative to Extraction for Severe Early Childhood Caries”
by Kunyawan Thaungwilai, Yanee Tantilertanant, Weerachai Singhatanadgit and Pairod Singhatanadgid
J. Clin. Med. 2023, 12(5), 1872; https://doi.org/10.3390/jcm12051872
Available online: https://www.mdpi.com/2077-0383/12/5/1872
15. “Depression in Children and Adolescents with Chronic Kidney Disease—Review of Available Literature”
by Natalia Dryjańska and Katarzyna Kiliś-Pstrusińska
J. Clin. Med. 2023, 12(10), 3554; https://doi.org/10.3390/jcm12103554
Available online: https://www.mdpi.com/2077-0383/12/10/3554
You are invited to view and submit relevant papers to the Journal of Clinical Medicine at the following link: https://www.mdpi.com/journal/jcm.
|
Special Issues |
|
|
“Endocrine Disorders in Children” Guest Editor: Dr. Juan Pedro López-Siguero Submission deadline: 25 December 2024
|
“Pediatric Palliative Care and Surgery” Guest Editors: Dr. Danielle B. Cameron and Dr. Amy Porter Submission deadline: 15 May 2025
|
|
Special Issue Reprint: |
“New Insights into Pediatric Pulmonology”
“Clinical Research Advances in Congenital Heart Disease”
Access more Special Issue books here.
JCM Editorial Office
16 October 2024
MDPI's Newly Launched Journals in September 2024
Five new journals covering a diverse range of subjects launched their inaugural issue in September 2024. Like other journals in MDPI’s portfolio, these journals are dedicated to sharing the latest research through open access, reflecting our commitment to making knowledge accessible to all.
We extend our sincere gratitude to the Editorial Board Members for their dedication to the launch and development of our new journals. Each journal will ensure its high-quality output via excellent editorial and rigorous peer-review processes so that the published articles achieve significant impact and broad visibility.
We invite you to explore and learn more about these new journals below.
| Journal | Founding Editor-in-Chief | Journal Topics (Selected) |
 |
Prof. Dr. Nejat Düzgüneş, University of the Pacific, USA | Editorial | view inaugural issue | biological therapy and stem-cell therapy; drug therapy; chemotherapy; radiation and other nonsurgical therapeutic strategies | view journal scope | submit an article |
 |
Prof. Dr. Magda Tsolaki, Greek Federation of Alzheimer’s Disease, Greece; Aristotle University of Thessaloniki, Greece | Editorial | view inaugural issue | surgical/procedural complications; complications; perioperative adverse events; postoperative adverse events | view journal scope | submit an article |
 |
Prof. Dr. Steven R. Fassnacht, Colorado State University, USA; Cooperative Institute for Research in the Atmosphere, USA | Editorial | view inaugural issue | ice as a mineral; atmospheric ice; sea ice; freshwater ice; ice sheets; ice caps and ice shelves | view journal scope | submit an article |
 |
Dr. Francisco Epelde, Hospital Universitari Parc Tauli, Spain; University Autonoma of Barcelona, Spain | Editorial | view inaugural issue | hospital management; hospital facilities; hospital services; hospital risk management; health law | view journal scope | submit an article |
 |
Prof. Dr. Nicola Ferri, University of Padova, Italy | Editorial | view inaugural issue | lipids in cells and whole organisms; lipid structure and function; lipid products and processes; dietary lipids and nutrition | view journal scope | submit an article |
We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here or contact the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.
9 October 2024
Journal of Clinical Medicine 2024 Editorial Board Meeting of the Section “Mental Health” Held on 24 September 2024
4 October 2024
MDPI INSIGHTS: The CEO's Letter #16 - UNGA79 Science Summit, OASPA, Peer Review Week
Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
MDPI Joins the Science Summit at UNGA79 (23–27 September 2024, New York)
On Friday 27 September, I had the privilege of giving the opening talk at the “Youth at the Science Summit” panel during the Science Summit conference, held in New York at the 79th session of the United Nations General Assembly (UNGA). Together, we discussed the future of science, publishing, innovation, and sustainable development.
It was a great opportunity to learn from our young leaders, whose voices must be included in the conversation as science shapes the future of artificial intelligence, climate mitigation, healthcare, technology, and more. This was also a powerful reminder of how essential global collaboration is in solving the major challenges we face. I left inspired by the dedication of these young researchers to making the world a better place!
Today’s youth are not just the leaders of tomorrow – they are already leading the change today.
Stefan Tochev (second from left) at the UNGA Science Summit 2024: “A great opportunity to learn from our young leaders.”
MDPI Supports the Future Generation of Scientists
This aligns with MDPI’s mission to support the next generation of scientists and early-career researchers by recognizing their achievements through our various MDPI awards, including the Young Investigator Awards, Best PhD Thesis Awards, Travel Awards, and more.
Our presence at this global event showed our commitment to advancing Open Science as a key driver for sustainable development. As a leading Open Access (OA) publisher, MDPI’s role at the summit was to emphasize the critical importance of democratizing scientific knowledge, making it accessible to all, and promoting global collaboration.
Through OA publishing, we aim to address pressing global challenges such as climate change, public health, and inequality, in line with the United Nations Sustainable Development Goals (SDGs).
“We aim to address pressing global challenges”
MDPI and the SDGs
In 2020, the SDG Publishers Compact was launched to accelerate implementation of the SDGs by promoting content that informs, develops, and inspires action. MDPI joined this initiative in 2021 and subsequently launched the MDPI SDG Hub in 2022, offering free access to recent research within the scope of each of the 17 SDGs.
During the summit, we highlighted the connection between Open Science and the SDG Publishers Compact, supporting the core objective to “Leave No One Behind” (LNOB). The transformative promise of the SDGs relies heavily on the Open Access model, which serves as a fundamental enabler of Open Science. We advocate for the wider adoption of Open Science practices in order to achieve the SDGs by 2030.
Impactful Research
Presenting at the 1st International Conference of Environmental Medicine
In September, MDPI and our journals IJERPH and Diseases sponsored and participated in the 1st International Conference of Environmental Medicine: Environmental Threats to Human Health: From Genetics to Epigenetics, held in Chieti, Italy.
The conference was organized in collaboration with various societies, including the Italian Society of Environmental Medicine (SIMA), one of more than 160 societies partnering MDPI journals.
The conference brought together influential figures from the Italian scholarly community, such as Antonio Felice Uricchio (President of the National Agency for University Research Assessment [ANVUR]), Alessandro Miani (President of SIMA), and Liborio Stuppia (Director of ‘Gabriele d’Annunzio’ University of Chieti-Pescara), among others.
MDPI was the sole publishing sponsor of the conference, at which I had the opportunity to present on behalf of the company. I provided an overview of MDPI, covering key facts and figures, the peer-review process, our strong collaboration with the Italian market, and insights into Nobel Prize winners who have published with MDPI, ahead of Sir Richard Roberts’ Nobel lecture.
“As at September 2024, 44 Nobel laureates have contributed to over 115 articles across 35 MDPI journals”
The keynote speaker at the event was Sir Richard Roberts, Nobel Laureate and 1993 Nobel Prize winner in Medicine, recognized for his discovery of split genes.
Nobel Laureates’ Contributions to MDPI
As at September 2024, 44 Nobel laureates have contributed to over 115 articles across 35 MDPI journals. I’ll share more details on this in the October newsletter.
Hosting such prominent figures in their respective fields, who play a significant role in advancing the OA movement, of which we are leaders in, resonates deeply with our editorial teams.
Sponsoring and supporting academic conferences is something we do on a large scale, and it continues to grow. Attending and speaking about MDPI shows our commitment by taking the time to connect with the scholarly community in person.
MDPI’s Presence in Italy
Italy ranks third globally in total MDPI publications, with nearly 130,000 contributions. We collaborate with about 12,000 Editorial Board Members in Italy, over 6,100 of whom have an H-index of more than 25.
We have 83 Editors-in-Chief and 209 Section Editors-in-Chief from Italy. We also support 20 Italian universities through our Institutional Open Access Program (IOAP) agreements with major institutions such as Sapienza University of Rome, the University of Milan, and the University of Pisa, among others.
Inside MDPI
Celebrating Peer Review Week, 23–27 September 2024
As we conclude another productive month at MDPI, I am pleased to highlight our participation in this year’s Peer Review Week (PRW), which took place from 23–27 September 2024. This global, community-driven celebration underscores the vital importance of peer review in maintaining the integrity and reliability of academic work. PRW provide a platform for institutions, publishers, and scholars to come together and reflect on the processes that uphold the quality of scholarly communication.
“We remain committed to enhancing the peer review process”
The theme for PRW 2024 was ‘Innovation and Technology in Peer Review.’ At MDPI, we were proud to contribute through various online and in-person events, including webinars from Europe, Asia-Pacific, and a roundtable discussion on innovation and technology in peer review. These events offer an opportunity to explore new tools and technologies that are shaping the future of peer review, particularly the integration of AI. As a company, we remain committed to enhancing the peer review process with innovative solutions while preserving the essential human expertise that makes it effective.
Peer Review Innovation and Technology at MDPI
Our efforts to improve peer review extend beyond the activities of this week. We also released a blog article discussing New Tools for Advancing Research Integrity and Peer Review, where we highlight two tools that MDPI has developed to support research integrity: Eureka – Reviewer Recommender and Online Proofreader. We are continually refining SuSy, our in-house submission system, to provide a seamless experience for authors and reviewers alike.
Listening to MDPI’s Authors and Reviewers
We highly value the time of our reviewers, and so do the authors who contribute to our journals. Our editorial process is bolstered by a network of dedicated reviewers, a team of over 6,000 diligent, well-trained staff members, and an in-house article submission platform designed to ensure efficient processes.
We make it a point to continually improve the experiences of both our authors and our reviewers throughout the entire editorial process, from submission to publication. This is why we regularly ask for feedback by conducting surveys. Here is what some of our respondents recently had to say about working with MDPI:
Coming Together for Science
ICM 2024 – Advances in Material Innovation
I am pleased to share that we held The 5th International Conference on Materials: Advances in Material Innovation (ICM 2024) in Basel, Switzerland this past 25–27 September.
This intimate event brought together leading scientists, researchers, and industry experts to exchange insights on recent advancements in materials characterization, processing, and manufacturing. Key focus areas included nanotechnology in material sciences and engineering, optical, electrical, and magnetic materials, soft, biological, and biomaterials, fibres, membranes, thin films, sensing materials, as well as materials and devices for energy and solar fuels. In addition, discussions featured the integration of AI and machine learning in materials research.
We received 90 abstract submissions. Over the course of the three-day event, 18 posters were displayed, and 34 talks were delivered, including three plenary speeches, seven invited talks, and 24 selected oral presentations.
A special thank-you to our partnering societies The Polish Membrane Society and The North American Thermal Analysis Society, as well as our sponsor, Nanomegas, for their support of the ICM conference. I am also pleased to share that we presented three awards, including the Best Presentation Award and two Best Poster Awards, recognizing the outstanding contributions of our participants.
Upcoming In-Person Event
7–9 October 2024
Non-coding RNA World 2024: Exploring Mechanisms, Designing Medicines
Location: Basel, Switzerland
ncRNA 2024 will explore the latest advances in the field, covering topics from basic biology to medical and technological applications.
Find more upcoming MDPI events here.
Closing Thoughts
Reflections from OASPA 2024 Conference in Lisbon (16–18 September)
Amidst my September travels, I also had pleasure of attending the OASPA 2024 Conference in Lisbon from 16–18 September. It’s the first in-person Open Access Scholarly Publishing Association (OASPA) event in five years, and being in the sunny city of Lisbon made it even better! MDPI has long been a member of OASPA, and attending this conference gave us an opportunity to connect with other key members of the organization to see the latest developments in the OA movement.
“I believe that publishers have a lot to offer in terms of data and insights”
Main Themes from OASPA 2024
The main themes covered were equity and inclusivity, diamond OA, AI and openness, OA books, research integrity, and how OA can address broader societal challenges such as climate change. While it was great to see the latest developments in these areas, it was also clear that certain voices were missing, particularly those of major publishers. Although it’s not easy to incorporate every perspective, I believe that publishers, including MDPI, have a lot to offer in terms of data and insights. During the membership meeting, a few of us raised the point that large-scale publisher input could add value to these discussions.
It’s important to participate in industry conferences such as OASPA in order to be part of the discussions and remain at the forefront of the OA movement.
It’s an opportunity to build meaningful relationships with organizations that share our commitment to OA.
While sponsorship is one way to show our support, it’s clear that being part of the conversation through participating in the OASPA groups and committee is what really makes a difference.
It took the last 20 years for more than 50% of the world's research to be published via open access. This provides a sobering reminder that flipping the remaining 50% will be a big challenge.
An important takeaway for me was that there is no "one-size-fits-all" solution for OA challenges: different regions and different stakeholders need different forms of support, whether it is infrastructure, funding, education, or policy, for example. I also enjoyed Rebecca Ross' presentation on how OA can drive action on climate. A few panellists shared the need for transparency in the peer-review process, advocating for open review reports, which is something we have been offering since 2014.
Speaking of openness, we are excited to celebrate Open Access Week 2024 with the scholarly community from 21–27 October. I look forward to sharing a recap of our activities in the next newsletter.
Chief Executive Officer
MDPI AG
3 October 2024
Journal of Clinical Medicine 2024 Editorial Board Meeting of the Section “Clinical Pediatrics” Held on 15 April 2024
1 October 2024
Journal of Clinical Medicine 2024 Editorial Board Meeting of the Section “Dermatology” Held on 30 May 2024
29 September 2024
MDPI New Journal Proposal—Invitation to Shape the Future of Open Science Together
